Open AccessLack of Weight Gain During the First 2 Months of Treatment and Human Immunodeficiency Virus Independently Predict Unsuccessful Treatment Outcomes in Tuberculosis
Author(s) -
Lauren S Peetluk,
Peter F Rebeiro,
Marcelo Cordeiro-Santos,
Afrânio Lineu Kritski,
Bruno B. Andrade,
Betina Durovni,
Solange Calvacante,
María B. Arriaga,
Megan Turner,
Marina C. Figueiredo,
Valeria Rolla,
Timothy R. Sterling
Publication year - 2019
Publication title -
the journal of infectious diseases (online. university of chicago press)/the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1093/infdis/jiz595
Subject(s) - medicine , pyrazinamide , tuberculosis , ethambutol , hazard ratio , weight change , confidence interval , confounding , weight loss , proportional hazards model , isoniazid , immunology , pathology , obesity
Weight change may inform tuberculosis treatment response, but its predictive power may be confounded by human immunodeficiency virus (HIV).